Clinical Trials Logo

Attention Deficit clinical trials

View clinical trials related to Attention Deficit.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05391698 Completed - Clinical trials for Attention Deficit Disorder With Hyperactivity

A Multimodal Intervention Program for Children With Attention Deficits (Child ViReal Support Program)

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The main aim of this study is the development and implementation of a multimodal intervention program consisting of parent training and child training which utilizes the potentials of immersive virtual reality technology (iVR) in order to test its effectiveness for children with attention deficits.

NCT ID: NCT05302362 Completed - Clinical trials for Traumatic Brain Injury

Effect of Fixed vs. Tailored Intensity tDCS for Attention Deficit After TBI

Start date: March 14, 2022
Phase: N/A
Study type: Interventional

Traumatic brain injury (TBI) is an important global health concern. Recently, advances in neurocritical care have led to an increase in the number of recovering TBI patients, and concomittantly in the incidence of complications of TBI. One of the most important sequalae of TBI is cognitive deficit, for which multimodal rehabilitation approach is indicated. Transcranial direct current stimulation (tDCS) is a promising treatment strategy for post-TBI cognitive deficits. However, a standardized tailored tDCS protocol is yet to be established for TBI patients. Therefore, this trial aims to 1) the efficacy of tDCS on post-TBI cognitive deficits, and 2) and optimized protocol of tDCS on post-TBI cognitive deficits via a three-arm double-blind, randomized controlled trial.

NCT ID: NCT04188626 Completed - Healthy Subjects Clinical Trials

Identification of Biomarkers to Predict Driver Take-over Control Quality

ANTIDOTE
Start date: December 9, 2019
Phase: N/A
Study type: Interventional

At level 3 conditionally automated, the vehicle ensures driving and the driver disengages from driving to perform another activity independent of driving (ex: read a book, play on his phone ....). However, drivers are expected to be available to take over control for the case of system failure or limitation. This take-over control must take place in a limited time, very short, of the order of a few seconds. To take-over control of the vehicle quickly and efficiently, the driver must be, at the time of take-over, vigilant, efficient, and attentive to the environment and focused on the take-over of manual driving. Predicting the driver's reengagement capabilities to ensure that the driver will be able to take-over control of the vehicle is crucial at level 3 of autonomous driving. The objective of ANTIDOTE is to determine physiological and behavioural parameters capable of predicting the take-over quality in level 3 conditionally automated vehicles in a simulated highway driving situation in healthy drivers or drivers with attention disorders.

NCT ID: NCT03490110 Completed - Stress Clinical Trials

Brain Markers of Improvements in Cognitive Functioning

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

Some of the most common, persistent, and disabling consequences of traumatic brain injury affect an individual's ability to achieve personal goals. Interventions that strengthen abilities such as being able to concentrate, remember, stay calm and overcome challenges, could have far reaching benefits for Veterans. One challenge in rehabilitation is that response to training can be highly variable, and a better understanding of the neural bases for this variability could inform care. This pilot project will test the clinical behavioral effects of a cognitive skill training intervention and explore to what extent changes in markers of the brain's electrical activity (using the non-invasive technique of electroencephalograms, EEG) can explain differences in responses to skill training.

NCT ID: NCT03318302 Completed - Sleep Disturbance Clinical Trials

Sleep and Exposure to Screens of Digital Media Devices in Israel

Start date: February 1, 2017
Phase: N/A
Study type: Observational

The aims of this survey are to assess the relationships between exposure to screens of digital media devices, sleep patterns, and daily function such as subjective sleepiness and attention abilities in adult Israel population

NCT ID: NCT02655276 Completed - Clinical trials for Stress, Psychological

Sublingual Glycine vs. Placebo on Attentional Difficulties and Hyperactivity in Prepuberal Children

Start date: January 2016
Phase: N/A
Study type: Interventional

This study is designed to investigate effects on attentional performance and motoric activity of 100 mg microencapsulated glycine (Bidicin® from Biotiki®) compared to placebo after treatment with t.i.d. sublingual doses over 3 weeks each. The primary objective of the study is to determine the effects on attentional performance and motoric activity of 100 mg microencapsulated Glycine (Bidicin® from Biotiki® ) compared to placebo after treatment with t.i.d. sublingual doses over 3 weeks each in children with low attentional performance and high motoric activity. A number of 30 prepuberal boys and girls aged 6 - 14 years with low attentional performance and high motoric activity will be enrolled in this study. The prepuberal status will be determined by Tanner stages ≤ 3.